Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MLAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 188.76M
March 31, 2026 186.24M
December 31, 2025 186.69M
September 30, 2025 178.47M
June 30, 2025 172.50M
March 31, 2025 159.83M
December 31, 2024 155.21M
September 30, 2024 161.45M
June 30, 2024 150.73M
March 31, 2024 145.39M
December 31, 2023 402.96M
September 30, 2023 387.76M
June 30, 2023 387.72M
March 31, 2023 393.48M
December 31, 2022 387.20M
September 30, 2022 374.24M
June 30, 2022 380.43M
March 31, 2022 393.80M
December 31, 2021 396.33M
September 30, 2021 399.42M
June 30, 2021 399.00M
March 31, 2021 406.23M
December 31, 2020 412.80M
September 30, 2020 392.41M
June 30, 2020 382.23M
Date Value
March 31, 2020 220.01M
December 31, 2019 234.17M
September 30, 2019 229.16M
June 30, 2019 119.05M
March 31, 2019 111.31M
December 31, 2018 107.59M
September 30, 2018 106.90M
June 30, 2018 105.45M
March 31, 2018 99.36M
December 31, 2017 94.45M
September 30, 2017 105.24M
June 30, 2017 100.99M
March 31, 2017 97.82M
December 31, 2016 93.72M
September 30, 2016 90.27M
June 30, 2016 87.66M
March 31, 2016 84.68M
December 31, 2015 80.64M
September 30, 2015 78.95M
June 30, 2015 76.39M
March 31, 2015 73.48M
December 31, 2014 71.72M
September 30, 2014 69.60M
June 30, 2014 66.40M
March 31, 2014 64.33M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 7.122B
Bio-Rad Laboratories, Inc. 7.174B
Bruker Corp. 2.381B
Danaher Corp. 52.58B
Harvard Bioscience, Inc. 7.418M

Shareholders Equity (Quarterly) Related Metrics